Arrowhead Pharmaceuticals (Germany) Analysis

Arrowhead Stock Analysis Notes

About 69.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 263.63. Arrowhead Pharmaceuticals recorded a loss per share of 1.29. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 17th of November 2011. Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. ARROWHEAD PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 116 people. To learn more about Arrowhead Pharmaceuticals call Christopher Anzalone at 626 304 3400 or check out https://arrowheadpharma.com.

Arrowhead Pharmaceuticals Investment Alerts

Arrowhead Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arrowhead Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Arrowhead Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Arrowhead Profitablity

The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.57.

Technical Drivers

As of the 18th of December 2024, Arrowhead Pharmaceuticals shows the Mean Deviation of 2.91, downside deviation of 3.77, and Risk Adjusted Performance of 0.0597. Arrowhead Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Arrowhead Pharmaceuticals information ratio, treynor ratio, value at risk, as well as the relationship between the jensen alpha and maximum drawdown to decide if Arrowhead Pharmaceuticals is priced correctly, providing market reflects its regular price of 21.1 per share.

Arrowhead Pharmaceuticals Price Movement Analysis

Arrowhead Pharmaceuticals Outstanding Bonds

Arrowhead Pharmaceuticals Predictive Daily Indicators

Arrowhead Pharmaceuticals Forecast Models

Arrowhead Pharmaceuticals' time-series forecasting models are one of many Arrowhead Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arrowhead Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Arrowhead Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arrowhead shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Arrowhead Pharmaceuticals. By using and applying Arrowhead Stock analysis, traders can create a robust methodology for identifying Arrowhead entry and exit points for their positions.

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.